US OptionsDetailed Quotes
CRWD241213C322500
- 0.00
- 0.000.00%
15min DelayClose Dec 13 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest322.50Strike Price0.00Turnover7214.04%IV-12.37%PremiumDec 13, 2024Expiry Date45.52Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9965Delta0.0006Gamma8.03Leverage Ratio-474.1454Theta0.0000Rho8.00Eff Leverage0.0000Vega
CrowdStrike Stock Discussion
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
9
1
4
$CrowdStrike (CRWD.US)$
Remember when the Crowdstrike update fiasco had all the bears hysterically spreading FUD while claiming that it was the end and everyone should dump their shares? Well, during that drop is where I bought in. I’m up 35.88% on my position already, before the year’s end. Fear is the mind-killer…
Remember when the Crowdstrike update fiasco had all the bears hysterically spreading FUD while claiming that it was the end and everyone should dump their shares? Well, during that drop is where I bought in. I’m up 35.88% on my position already, before the year’s end. Fear is the mind-killer…
1
3
$CrowdStrike (CRWD.US)$ back to 360!
1
Over the past few weeks, industry leaders like $Salesforce (CRM.US)$ , $Intuit (INTU.US)$ , and $Snowflake (SNOW.US)$ have showcased how Al is reshaping their offerings.
Cybersecurity firms are no exception, demonstrating that innovation in security is keeping pace with broader enterprise trends.
As Al shifts from hype to application, a pivotal moment has emerged. Autonomous Al agents are driving enterprise innovation, automating pro...
Cybersecurity firms are no exception, demonstrating that innovation in security is keeping pace with broader enterprise trends.
As Al shifts from hype to application, a pivotal moment has emerged. Autonomous Al agents are driving enterprise innovation, automating pro...
7
1
$CrowdStrike (CRWD.US)$ you would think this guy's invented life itself with this p/e
1
$CrowdStrike (CRWD.US)$ 334..
1
4
thanks
$CrowdStrike (CRWD.US)$
$CrowdStrike (CRWD.US)$
This could be potential double top formation.
$CrowdStrike (CRWD.US)$
starting to lose momentum in weekly day.
$CrowdStrike (CRWD.US)$
This could be potential double top formation.
$CrowdStrike (CRWD.US)$
starting to lose momentum in weekly day.
3
9
1
The S&P 500 is on track to close the year with a gain of around 28%, after setting 57 record highs this year.
At the moment, the Wall Street is partying like it’s 1998 as market optimism fuels gains unmatched since the 2000 dot-com bubble.
This bullish market momentum is so strong to a point where it seems like nothing will disrupt it. Well, is that really the case?
$Salesforce (CRM.US)$ $CrowdStrike (CRWD.US)$ $Nike (NKE.US)$ $Taiwan Semiconductor (TSM.US)$ $Advanced Micro Devices (AMD.US)$ $Johnson & Johnson (JNJ.US)$ $Disney (DIS.US)$ $Sea (SE.US)$ $Grab Holdings (GRAB.US)$ $iShares Bitcoin Trust (IBIT.US)$ $Intel (INTC.US)$ ...
At the moment, the Wall Street is partying like it’s 1998 as market optimism fuels gains unmatched since the 2000 dot-com bubble.
This bullish market momentum is so strong to a point where it seems like nothing will disrupt it. Well, is that really the case?
$Salesforce (CRM.US)$ $CrowdStrike (CRWD.US)$ $Nike (NKE.US)$ $Taiwan Semiconductor (TSM.US)$ $Advanced Micro Devices (AMD.US)$ $Johnson & Johnson (JNJ.US)$ $Disney (DIS.US)$ $Sea (SE.US)$ $Grab Holdings (GRAB.US)$ $iShares Bitcoin Trust (IBIT.US)$ $Intel (INTC.US)$ ...
From YouTube
27
No comment yet
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.